Stock listing

OTC:BAYRY Bayer AG Stock

US listing (OTC) of Bayer AG · home listing Xetra:BAYN

Follow Bayer AG into a list and get an email when it puts out news.

Share price · OTC:BAYRY

$12.81 USD +0.49 (+4.0%)

Close on Oct 27, 2026

Day range
$12.47 – $12.81 USDOct 27, 2026
Volume
120,253 sharesOct 27, 2026
Market cap
$50.34B USDAt the close on Oct 27, 2026 · price × 3.93B shares outstanding
Bayer AG logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Xetra:BAYN · Home€50.58 EUR+2.62 (+5.5%)5,109,338€50.26€50.66€49.49€47.96Close on Oct 30, 2026
BET:BAYER18,425 HUF+1,245 (+7.2%)30418,28018,42518,08017,180Close on Oct 30, 2026
OTC:BAYRY$12.81 USD+0.49 (+4.0%)120,253$12.47$12.81$12.47$12.32Close on Oct 27, 2026
Frankfurt:BAYN€50.40 EUR+4.42 (+9.6%)—€50.22€50.50€49.66€45.98Close on Oct 30, 2026
OTC:BAYZF$50.56 USD+1.18 (+2.4%)800$50.56$50.56$50.56$49.38Close on Oct 27, 2026
Munich:BAYN€45.60 EUR+1.50 (+3.4%)28€45.63€45.63€45.60€44.10Close on Oct 27, 2026
Dusseldorf:BAYN€50.14 EUR+4.15 (+9.0%)889€50.02€50.58€49.74€45.99Close on Oct 30, 2026
Hamburg:BAYN€50.14 EUR+4.23 (+9.2%)269€50.12€50.14€49.80€45.91Close on Oct 30, 2026
Frankfurt:BAYA€12.70 EUR+1.50 (+13.4%)—€12.30€12.70€12.30€11.20Close on Oct 30, 2026
Ticker
OTC:BAYRY
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Bayer (Xetra:BAYN) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 8:00 AM ET

    Watch Transcript

  • Bayer (Xetra:BAYN) Q1 2026 Earnings Call

    Tue, May 12, 2026 · 4:00 AM ET

    Watch Transcript

  • Bayer (Xetra:BAYN) Q4 2025 Earnings Call

    Wed, Mar 04, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

Bayer Shares New Post Hoc Analysis Of Self-Reported Sleep-Related Outcomes with Lynkuet® (elinzanetant) in Women with Moderate to Severe Vasomotor Symptoms at the Menopause Society Annual Meeting

Oct 26, 2026

Asundexian first Factor XIa inhibitor approved in China for stroke risk reduction after priority review

Oct 26, 2026

ESMO 2026: NUBEQA® (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence

Oct 24, 2026

Bayer to Present New Cardiac Amyloidosis and Heart Failure Data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting

Oct 8, 2026

Actress and Menopause Advocate Melissa Joan Hart Partners with Bayer to Raise Awareness about Lynkuet® (elinzanetant), a Prescription Treatment for Moderate to Severe Hot Flashes due to Menopause

Oct 8, 2026

U.S. FDA Accepts Bayer’s Supplemental New Drug Application for KERENDIA® (finerenone) to Treat Adults with Chronic Kidney Disease (CKD) Without Diabetes

Oct 8, 2026

Bayer to Invest $2.2 Billion in a New Manufacturing Site in Ohio

Oct 2, 2026

Bayer to Invest 2.2 Billion U.S. Dollars in a New Manufacturing Site in the United States

Oct 2, 2026

Bayer appoints Dr. Christoph Koenen, MD, as Chief Medical Officer

Oct 1, 2026

BlueRock Therapeutics’ investigational cell therapy lemiretprocel (OpCT-001) for primary photoreceptor diseases granted orphan drug designations by FDA and EMA

Sep 30, 2026

All Bayer AG news

Financings

  • Strategic investment of minority stake in new entity holding LARC business

    Aug 4, 2026 · US$3.43B

    Update: €3B

    Buyers: Apollo (Apollo-managed funds and affiliates will obtain a minority, non-controlling stake in a newly established entity holding Bayer's LARC business); Apollo-managed funds and affiliates (minority, non-controlling stake in exchange for a €3.0 billion capital contribution)

    Use of proceeds: Improve capital structure and financial flexibility amid liquidity needs from bond maturities and litigation

    Announced Jul 10, 2026 · Update Aug 4, 2026

Read by 6ix AI from the company's releases

Decks

Bayer AG on 6ix

News releases
107 in the last 12 months · 140 in all · newest Oct 26, 2026 · oldest 2025
Calls
10 calls with a replay · 10 with a transcript · latest Aug 4, 2026
Decks
191 decks · latest Aug 31, 2026

Where Bayer AG is listed

ListingExchangeCountryCurrency
Xetra:BAYN · Home listingXetraGermanyEUR
gettex:BAYNgettexGermanyEUR
Tradegate:BAYNTradegateGermanyEUR
BET:BAYERBETHungaryHUF
OTC:BAYRY · This pageOTCUnited StatesUSD
Milan:1BAYNMilanItalyEUR
Frankfurt:BAYNFrankfurtGermanyEUR
Lang & Schwarz:BAY001Lang & SchwarzGermanyEUR
LS Exchange:BAY001LS ExchangeGermanyEUR
OTC:BAYZFOTCUnited StatesUSD
LSIN:0P6SLSINUnited KingdomEUR
EUROTLX:4BAYNEUROTLXItalyEUR
Stuttgart:BAYNStuttgartGermanyEUR
Munich:BAYNMunichGermanyEUR
GPW:BAYGPWPolandPLN
BMV:BAYNNBMVMexicoMXN
Dusseldorf:BAYNDusseldorfGermanyEUR
BCBA:BAYNBCBAArgentinaARS
gettex:BAYAgettexGermanyEUR
Hamburg:BAYNHamburgGermanyEUR
BVB:BAYNBVBRomaniaRON
SIX Swiss:BAYNSIX SwissSwitzerlandCHF
Frankfurt:BAYAFrankfurtGermanyEUR
VIE:BAYNViennaAustriaEUR
Aquis:BAYNDAquisUnited KingdomEUR
BX Swiss:BAYNBX SwissSwitzerlandCHF
BX Swiss:BAYNEURBX SwissSwitzerlandEUR
Aquis:BAYNDAquisUnited KingdomEUR
BSESOF:BAYNBSESOFBulgariaEUR
LS Exchange:879501LS ExchangeGermanyEUR
Turquoise:BAYNDTurquoiseUnited KingdomEUR
Hanover:BAYNHanoverGermanyEUR
Munich:BAYAMunichGermanyEUR
BIVA:BAYNNBIVAMexicoMXN
Dusseldorf:BAYADusseldorfGermanyEUR
Lang & Schwarz:879501Lang & SchwarzGermanyEUR
Stuttgart:BAYAStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Bayer AG.